Farhadi A, Banan A, Fields J, Banan ALI, Keshavarzian ALI. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol. 2003;18(5):479–97. https://doi.org/10.1046/j.1440-1746.2003.03032.x.

Article  PubMed  Google Scholar 

Citi S. Intestinal barriers protect against disease. Science. 2018;359(6380):1097–8.

Article  CAS  PubMed  Google Scholar 

Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–72.

Article  CAS  PubMed  Google Scholar 

Hanning N, Edwinson AL, Ceuleers H, et al. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol. 2021;14:1756284821993586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601–9.

Article  CAS  PubMed  Google Scholar 

Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest. 2005;115(10):2702–15. https://doi.org/10.1172/JCI24970.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai YH, Tai CY. The conventional short-circuiting technique under-short-circuits most epithelia. J Membr Biol. 1981;59(3):173–7.

Article  CAS  PubMed  Google Scholar 

Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.

Article  CAS  PubMed  Google Scholar 

Minoda Y, Esaki M, Ihara E, Nagatomo S, Nishioka K, Fujimori N, et al. Auxiliary diagnosis of subepithelial lesions by impedance measurement during EUS-guided fine-needle biopsy. Gastrointest Endosc. 2023;97(5):977–84. https://doi.org/10.1016/j.gie.2022.11.022.

Article  PubMed  Google Scholar 

Komori K, Ihara E, Minoda Y, et al. The altered mucosal barrier function in the duodenum plays a role in the pathogenesis of functional dyspepsia. Dig Dis Sci. 2019;64(11):3228–39.

Article  CAS  PubMed  Google Scholar 

Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese clinical practice guideline for diabetes 2019. J Diabetes Investig. 2020;11(4):1020–76. https://doi.org/10.1111/jdi.13306.

Article  PubMed  PubMed Central  Google Scholar 

Douglas GM, Maffei VJ, Zaneveld JR, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikeda H, Ihara E, Takeya K, et al. The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia. J Gastroenterol. 2024;59(5):361–75.

Article  CAS  PubMed  Google Scholar 

Miyamoto J, Watanabe K, Taira S, Kasubuchi M, Li X, Irie J, et al. Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice. PLoS ONE. 2018;13(4):e0196579. https://doi.org/10.1371/journal.pone.0196579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond). 2012;36(11):1442–9. https://doi.org/10.1038/ijo.2011.256.

Article  CAS  PubMed  Google Scholar 

Takeuchi T, Kameyama K, Miyauchi E, et al. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab. 2023;35(2):361-75.e9.

Article  CAS  PubMed  Google Scholar 

Zafar H, Saier MH. Gut Bacteroides species in health and disease. Gut Microbes. 2021;13(1):1–20.

Article  PubMed  Google Scholar 

Wexler AG, Goodman AL. An insider’s perspective: bacteroides as a window into the microbiome. Nat Microbiol. 2017;2:17026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138(22):2486–98.

Article  CAS  PubMed  Google Scholar 

Thaiss CA, Levy M, Grosheva I, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359(6382):1376–83.

Article  CAS  PubMed  Google Scholar 

Mueller NT, Differding MK, Zhang M, et al. Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial. Diabetes Care. 2021;44(7):1462–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Ren H, Zhao C, et al. Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6-month, two-arm randomised trial. Diabetologia. 2022;65(10):1613–26.

Article  CAS  PubMed  PubMed Central  Google Scholar